TABLE 3.
Comparative analysis of inflammatory biomarkers in osteoarticular mycoses
| Type of infection (reference[s]) | No. of cases | Median ESR (mm/h) (range) | Median CRP concn (mg/dL) (range)a | Median WBC count (cells/μL) (range) |
|---|---|---|---|---|
| Candida osteomyelitis (1; case in this report) | 208 | 65 (3–150) | 8.8 (1.2–46) | 10,100 (2,650–36,000) |
| Candida arthritis (2) | 112 | 56 (10–118) | 28.9 (0.5–141) | 10,750 (160–36,500) |
| Candida bursitis (292–294, 296, 297) | 12 | 79 (48–106) | 5.4 (1.2–6.7) | 6,810 (500–11,700) |
| Aspergillus osteomyelitis (550) | 180 | 86 (10–148) | 51 (1.5–151) | 8,740 (100–37,000) |
| Aspergillus arthritis (572; case in this report) | 32 | 91 (46–148) | 3.7 (2.6–4.6) | 9,700 (1,300–12,700) |
| Non-Aspergillus mold osteomyelitis (1232) | 148 | 76 (32–120) | 45 (1.1–362) | 9,850 (1,900–33,500) |
| Osteoarticular mucormycosis (739; cases in this report) | 35 | 69 (40–107) | NA | 16,150 (500–29,400) |
a
NA, not applicable.